Michael J. Kozal

4.4k total citations
57 papers, 3.1k citations indexed

About

Michael J. Kozal is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Michael J. Kozal has authored 57 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Infectious Diseases, 46 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Michael J. Kozal's work include HIV/AIDS drug development and treatment (48 papers), HIV Research and Treatment (46 papers) and HIV/AIDS Research and Interventions (35 papers). Michael J. Kozal is often cited by papers focused on HIV/AIDS drug development and treatment (48 papers), HIV Research and Treatment (46 papers) and HIV/AIDS Research and Interventions (35 papers). Michael J. Kozal collaborates with scholars based in United States, United Kingdom and Spain. Michael J. Kozal's co-authors include Jennifer Chiarella, Max Lataillade, Nila Shah, Don Morris, Naiping Shen, Earl Hubbell, Michael D. Miller, Mark A. Winters, Birgitte B. Simen and Katherine Huppler Hullsiek and has published in prestigious journals such as The Lancet, Nature Medicine and Annals of Internal Medicine.

In The Last Decade

Michael J. Kozal

55 papers receiving 3.0k citations

Peers

Countries citing papers authored by Michael J. Kozal

Since Specialization

Citations

This map shows the geographic impact of Michael J. Kozal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Kozal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Kozal more than expected).

Fields of papers citing papers by Michael J. Kozal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Kozal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Kozal. The network helps show where Michael J. Kozal may publish in the future.

Co-authorship network of co-authors of Michael J. Kozal

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Kozal. A scholar is included among the top collaborators of Michael J. Kozal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Kozal. Michael J. Kozal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transmitted HIV‐1 drug resistance in a large international cohort using next‐generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study 2020 ·HIV Medicine ·John D. Baxter, David Dunn, Anna Tostevin, Rasmus L. Marvig, Marc Bennedbæk, Alessandro Cozzi‐Lepri, Shweta Sharma, Michael J. Kozal, Mark Gompels, Angie N. Pinto, Jens Lundgren, (unknown)	14
2	Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders 2019 ·Journal of Medical Virology ·Michael Fuchs, Alexander Monto, Norbert Bräu, (unknown), Warren N. Schmidt, Michael J. Kozal, Susanna Naggie, Ramsey Cheung, Gretja Schnell, Yao Yu, (unknown), (unknown), Daniel E. Cohen, Doris H. Toro	1
3	HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China 2016 ·PLoS ONE ·Xi Chen, (unknown), Jianmei He, (unknown), Jennifer Chiarella, Michael J. Kozal	14
4	Transmission of HIV drug resistance 2014 ·Current Opinion in Infectious Diseases ·Anna María Geretti, Roger Paredes, Michael J. Kozal	8
5	Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China 2014 ·PLoS ONE ·(unknown), Xi Chen, (unknown), Ann B. Williams, Honghong Wang, Jianmei He, (unknown), Jennifer Chiarella, (unknown), Gregory S. Turenchalk, Michael J. Kozal	14
6	Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment 2013 ·Journal of Addiction Medicine ·Jeanette M. Tetrault, Michael J. Kozal, Jennifer Chiarella, Lynn E. Sullivan, (unknown), David A. Fiellin	7
7	Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing 2012 ·PLoS ONE ·Max Lataillade, Jennifer Chiarella, Rong Yang, (unknown), Jonathan Uy, Daniel Seekins, Birgitte B. Simen, Elizabeth St. John, (unknown), Michael J. Kozal	31
8	Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic Failure 2012 ·The Journal of Infectious Diseases ·Jonathan Z. Li, Roger Paredes, Heather J. Ribaudo, Michael J. Kozal, Evguenia S. Svarovskaia, Jeffrey A. Johnson, Anna María Geretti, Karin J. Metzner, Martin R. Jakobsen, Katherine Huppler Hullsiek, Lars Østergaard, Michael D. Miller, Daniel R. Kuritzkes	37
9	Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure 2011 ·AIDS ·Jonathan Z. Li, Roger Paredes, Heather J. Ribaudo, Evguenia S. Svarovskaia, Michael J. Kozal, Kathy Huppler Hullsiek, Michael D. Miller, David R. Bangsberg, Daniel R. Kuritzkes	70
10	Development of an Electronic Medical Record-Based Clinical Decision Support Tool to Improve HIV Symptom Management 2009 ·AIDS Patient Care and STDs ·(unknown), Joel Tsevat, Amy C. Justice, Joseph Mrus, Forrest L. Levin, Michael J. Kozal, Kristin Mattocks, (unknown), Michelle Rogers, Joseph Erdos, Cynthia Brandt, Ian Kudel, R. Scott Braithwaite	13
11	Review: Hepatitis C Protease and Polymerase Inhibitors in Development 2008 ·AIDS Patient Care and STDs ·(unknown), Michael J. Kozal	40
12	The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy Strategies 2007 ·HIV Clinical Trials ·Michael J. Kozal, Katherine Huppler Hullsiek, Rodger D. MacArthur, Mary van den Berg-Wolf, Grace Peng, Ying Xiang, John D. Baxter, Jonathan Uy, Edward E. Telzak, Richard M. Novak, (unknown)	41
13	A Population‐Based and Longitudinal Study of Sexual Behavior and Multidrug‐Resistant HIV Among Patients in Clinical Care 2006 ·Journal of the International AIDS Society ·Michael J. Kozal, K. Rivet Amico, Jennifer Chiarella, Deborah H. Cornman, William A. Fisher, Jeffrey D. Fisher, Gerald Friedland	12
14	The Hunt for HIV-1 Integrase Inhibitors 2006 ·AIDS Patient Care and STDs ·Max Lataillade, Michael J. Kozal	44
15	Prevalence and Impact of HIV-1 Protease Codon 33 Mutations and Polymorphisms in Treatment-Naive and Treatment-Experienced Patients 2006 ·Antiviral Therapy ·Michael J. Kozal, Katherine Huppler Hullsiek, Robert Leduc, Richard M. Novak, Rodger D. MacArthur, Jody Lawrence, John D. Baxter	7
16	Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy 2005 ·Clinical Infectious Diseases ·Richard M. Novak, (unknown), Rodger D. MacArthur, John D. Baxter, Katherine Huppler Hullsiek, Grace Peng, Ying Xiang, (unknown), Barry Schmetter, J. Uy, Mary van den Berg-Wolf, Michael J. Kozal	104
17	Review: Cross-Resistance Patterns Among HIV Protease Inhibitors 2004 ·AIDS Patient Care and STDs ·Michael J. Kozal	28
18	Detection Of Drug Resistance Mutations In The Human Immunodeficiency Virus Type I (HIV-I) pol Gene: Differences In Semen And Blood HIV-I RNA And Proviral DNA 1994 ·The Journal of Infectious Diseases ·(unknown), Michael J. Kozal, Kamal Hamed, Mark A. Winters, T. C. Merigan	54
19	Combination Therapy with Zidovudine and Didanosine Selects for Drug-Resistant Human Immunodeficiency Virus Type 1 Strains with Unique Patterns of pol Gene Mutations 1994 ·The Journal of Infectious Diseases ·Robert W. Shafer, Michael J. Kozal, Mark A. Winters, Astrid K. N. Iversen, David Katzenstein, Margaret V. Ragni, William A. Meyer, Parul Gupta, S Rasheed, Robert W. Coombs, Michael Katzman, Susan A. Fiscus, T. C. Merigan	175
20	A Mutation in Human Immunodeficiency Virus Reverse Transcriptase and Decline in CD4 Lymphocyte Numbers in Long-Term Zidovudine Recipients 1993 ·The Journal of Infectious Diseases ·Michael J. Kozal, Robert W. Shafer, Mark A. Winters, David Katzenstein, T. C. Merigan	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact